Newest figures come from the 10-K for FY2025, filed Mar 16, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the KYIVW SEC filings page.
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) reported $1.2B in revenue for fiscal year 2025, up 25.9% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue expansion is being accompanied by an earnings-quality split: cash generation strengthened while reported profitability sharply compressed.
In FY2025, net income fell to$124M from$283M , yet operating cash flow rose to$558M from$430M and free cash flow reached$311M . That divergence means the earnings decline did not translate proportionally into cash generation, pointing to non-cash or timing effects that the supplied line items do not identify.
The business expanded revenue to
The balance sheet became less leveraged: total liabilities declined to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Kyivstar Group Ltd. Warrant expiring 8/14/2030's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Kyivstar Group Ltd. Warrant expiring 8/14/2030, and counted as zero in the overall score.
Kyivstar Group Ltd. Warrant expiring 8/14/2030's revenue surged 25.9% year-over-year to $1.2B, reflecting rapid business expansion. This strong growth earns a score of 70/100.
Kyivstar Group Ltd. Warrant expiring 8/14/2030 has a moderate D/E ratio of 0.63. This balance of debt and equity financing earns a leverage score of 56/100.
Kyivstar Group Ltd. Warrant expiring 8/14/2030's current ratio of 1.39 indicates adequate short-term liquidity, earning a score of 37/100. The company can meet its near-term obligations, though with limited headroom.
Kyivstar Group Ltd. Warrant expiring 8/14/2030 converts 26.9% of revenue into free cash flow ($311.0M). This strong cash generation earns a score of 94/100.
Not available for Kyivstar Group Ltd. Warrant expiring 8/14/2030, and counted as zero in the overall score.
Kyivstar Group Ltd. Warrant expiring 8/14/2030 passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Kyivstar Group Ltd. Warrant expiring 8/14/2030 generates $4.50 in operating cash flow ($558.0M OCF vs $124.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Kyivstar Group Ltd. Warrant expiring 8/14/2030 generated $61.0M in free cash flow in Q4 2025, representing cash available after capex. This represents an increase of 15.1% from the same quarter a year earlier.
Kyivstar Group Ltd. Warrant expiring 8/14/2030 held $455.0M in cash as of Q4 2025; long-term debt is not reported for that period.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
Kyivstar Group Ltd. Warrant expiring 8/14/2030 invested $91.0M in capex in Q4 2025, funding long-term assets and infrastructure. This represents an increase of 71.7% from the same quarter a year earlier.
Not reported for Q4 2025.
Not reported for Q4 2025.
KYIVW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, EPS (Basic), EPS (Diluted).
KYIVW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2510-K | Q3'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|
| Total Assets | $2.1B-3.9% | $2.0B | $2.2B | N/A |
| Current Assets | $692.0M-42.7% | $688.0M | $1.2B | N/A |
| Cash & Equivalents | $455.0M-32.5% | $472.0M-7.6% | $674.0M | $511.0M |
| Inventory | $3.0M0.0% | $2.0M | $3.0M | N/A |
| Accounts Receivable | $37.0M-7.5% | $37.0M | $40.0M | N/A |
| Goodwill | $128.0M+814.3% | $124.0M+785.7% | $14.0M | $14.0M |
| Total Liabilities | $823.0M-27.1% | $797.0M | $1.1B | N/A |
| Current Liabilities | $498.0M-43.9% | $491.0M | $887.0M | N/A |
| Non-Current Liabilities | $325.0M+34.3% | $306.0M | $242.0M | N/A |
| Total Equity | $1.3B+20.3% | $1.2B+22.0% | $1.1B | $1.0B |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Long-Term Debt, Retained Earnings.
KYIVW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Dividends Paid, Share Buybacks.
KYIVW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Kyivstar Group Ltd. Warrant expiring 8/14/2030 KYIVW | FY2025 | $1.2B | $124.0M | 10.7% | N/A | 43/100 |
| Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock LBRDP | FY2025 | N/A | -$2.7B | N/A | N/A | — |
| KORE Group Holdings, Inc. KORE | FY2025 | $285.9M | -$63.0M | -22.0% | $163.0M | 25/100 |
| IQSTEL INC. IQST | FY2025 | $316.9M | -$8.5M | -2.7% | $10.9M | 47/100 |
| iOThree Limited IOTR | FY2026 | $14.7M | -$1.2M | -7.9% | $9.4M | 41/100 |
Where Kyivstar Group Ltd. Warrant expiring 8/14/2030 Ranks
Frequently Asked Questions
What is Kyivstar Group Ltd. Warrant expiring 8/14/2030's annual revenue?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) reported $1.2B in total revenue for fiscal year 2025. This represents a 25.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Kyivstar Group Ltd. Warrant expiring 8/14/2030's revenue growing?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) revenue grew by 25.9% year-over-year, from $919.0M to $1.2B in fiscal year 2025.
Is Kyivstar Group Ltd. Warrant expiring 8/14/2030 profitable?
Yes, Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) reported a net income of $124.0M in fiscal year 2025, with a net profit margin of 10.7%.
What is Kyivstar Group Ltd. Warrant expiring 8/14/2030's net profit margin?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) had a net profit margin of 10.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Kyivstar Group Ltd. Warrant expiring 8/14/2030's return on equity (ROE)?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) has a return on equity of 9.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Kyivstar Group Ltd. Warrant expiring 8/14/2030's free cash flow?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) generated $311.0M in free cash flow during fiscal year 2025. This represents a 16.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Kyivstar Group Ltd. Warrant expiring 8/14/2030's operating cash flow?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) generated $558.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Kyivstar Group Ltd. Warrant expiring 8/14/2030's total assets?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) had $2.1B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Kyivstar Group Ltd. Warrant expiring 8/14/2030's capital expenditures?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) invested $247.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Kyivstar Group Ltd. Warrant expiring 8/14/2030's current ratio?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) had a current ratio of 1.39 as of fiscal year 2025, which is considered adequate.
What is Kyivstar Group Ltd. Warrant expiring 8/14/2030's debt-to-equity ratio?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) had a debt-to-equity ratio of 0.63 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Kyivstar Group Ltd. Warrant expiring 8/14/2030's return on assets (ROA)?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) had a return on assets of 5.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Kyivstar Group Ltd. Warrant expiring 8/14/2030's Piotroski F-Score?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Kyivstar Group Ltd. Warrant expiring 8/14/2030's earnings high quality?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) has an earnings quality ratio of 4.50x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Kyivstar Group Ltd. Warrant expiring 8/14/2030?
Kyivstar Group Ltd. Warrant expiring 8/14/2030 (KYIVW) scores 43 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.